The average one-year price target for Panacea Acquisition - Equity Warrant (NYSE:NUVB.WS) has been revised to $0.04 / share. This is a decrease of 72.02% from the prior estimate of $0.16 dated January ...

Q4 2025 Management View CEO R. Norwitt highlighted a record-breaking fourth quarter, citing "sales and adjusted diluted ...

Ondas stock rose 2.8% on Rotron Aero acquisition news while Stifel and Northland analysts raised price targets to $16-$18 on growth outlook.

Sprinklr Inc. (NYSE:CXM) is one of the Best Tech Stocks Under $10 to Buy, at least based on a bullish analysis report from Citizens. The analyst, who maintained Sprinklr’s Market Outperform rating and ...

SSEA and Forever Young have agreed to use reasonable best efforts to negotiate and execute a definitive agreement as soon as practicable. Pursuant to the LOI, the parties contemplate that the ...

Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. The deal, first announced in ...

Management anticipates the SWK transaction to scale the portfolio to $1.2 billion on a September 30 pro forma basis and optimize leverage at approximately 1.1x. “We anticipate this transaction will ...

Nukkleus Inc (NASDAQ: NUKK) shares climbed Tuesday after the company said its planned acquisition, Rimon, stands to gain from a major Iron Dome expansion deal. What Happened: Nukkleus, which acquires ...

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Baird reiterated its Outperform rating on Mirum Pharmaceuticals Inc.

The average one-year price target for Panacea Acquisition - Equity Warrant (NYSE:NUVB.WS) has been revised to $0.16 / share. This is a decrease of 72.98% from the prior estimate of $0.59 dated ...